StockData
Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd (TAK) income statement

TAKNYSEPharmaceutical PreparationsAlso trades as TKPHF
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30
$21.27−0.37 (-1.71%)

Close on Nov 18, 2026Market cap $73.30BP/E –Yield –

Takeda Pharmaceutical Co Ltd income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin
65.1%
Operating margin
0.1%
Net margin
-3.4%
Return on equity, FY2026
-2.1%

Financial strength

Current ratio
1.09
Debt to equity
0.66
Debt to assets
31.5%
Cash to current liabilities
21.0%

Valuation

P/E ratio
–
Price to sales
2.60
Price to book
1.58
Dividend yield
–

See a number that looks wrong?